MIRA CONNECT Study
ConditionPregnancy of Unknown Location (PUL)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorUniversity of Colorado, Denver
About this trial
The goal of this pilot study is to assess the accuracy and precision of an at-home quantitative urine beta hCG (b-hCG) test in the management of pregnancy of unknown location (PUL).
Eligibility criteria
Qualifiers
Non-pregnant
Diagnosed with PUL requiring ongoing surveillance of serum hCG levels
Disqualifiers
History of renal disease
History of type I or type II diabetes
Known malignancy of any diagnosis including hCG-secreting tumors (hepatobiliary tumors and neuroendocrine tumors) and ovarian germ cell tumors.
Gestational Trophoblastic Disease
Trial design
Treatments tested in this trial
- at-home quantitative urine b-hCG test
Treatment groups
35 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov